Zaroxolyn

Active Ingredient(s): Metolazone
FDA Approved: * November 27, 1973
Pharm Company: * UCB INC
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zaroxolyn Overview

Metolazone is a thiazide-like diuretic marketed under the brand names Zytanix from Zydus Cadila, Zaroxolyn, and Mykrox. It is primarily used to treat congestive heart failure and high blood pressure. Metolazone indirectly decreases the amount of water reabsorbed into the bloodstream by the kidney, so that blood volume decreases and urine volume increases. This lowers blood pressure and prevents excess fluid accumulation in heart failure. Metolazone is sometimes used together with loop diureti...

Read more Zaroxolyn Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metolazone

Recent Zaroxolyn Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Metolazone
  • Tablet: 0.5mg, 10mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zaroxolyn: (3 results)

Sorted by National Drug Code
  • 53014-850 Zaroxolyn 5 mg Oral Tablet by Unither Manufacturing LLC
  • 53014-975 Zaroxolyn 2.5 mg Oral Tablet by Unither Manufacturing LLC
  • 68151-2943 Zaroxolyn 2.5 mg Oral Tablet by Carilion Materials Management

Other drugs which contain Metolazone or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA